Literature DB >> 20167234

Phenotype markers and cytokine intracellular production by CD8+ gammadelta T lymphocytes do not support a regulatory T profile in Behçet's disease patients and healthy controls.

Antonio Clemente1, Ana Cambra, Iván Munoz-Saá, Catalina Crespí, Lucio Pallarés, Antonio Juan, Núria Matamoros, Maria Rosa Julià.   

Abstract

gammadelta T lymphocytes (GD) have been suggested as one of the causes of cytokine dysregulation that results in neutrophils hyperactivation in Behçet's disease (BD) patients. In addition, GD can provoke cytotoxic lesions in autoimmune diseases by interaction with MICA (MHC class I chain-related A) molecules, through NKG2D receptor on its surface. In contrast, the CD8+ subset of gammadelta T lymphocytes (GDCD8+) has been related to regulatory T activity. The aim of this study was to determine the phenotype and the intracellular cytokine profile in GD from peripheral blood, to discern if they were skewed to an effector or regulatory pattern in BD. We performed phenotype analysis, by three-colour flow cytometry, in 28 BD, 15 healthy controls (HC) and 14 patients with recurrent bucal ulcers (RBU). We studied intracellular cytokine production in 10 BD and 14 HC, after polyclonal stimulation. In addition, we analysed serum IL-15 and soluble MICA, by ELISA, in 27 BD, 21 HC and 40 rheumatoid arthritis patients. The hallmark in BD was a specific increase in CD8 expression by GD, and in GDCD8+ absolute numbers. Most of GDCD8+ presented CD8 alphaalpha homodimers and were negative for CD103, Foxp3 and CTLA-4. GDCD8+ and GDCD8- were high IFNgamma-, but poor IL-2, IL-10, TGFbeta and IL-4-producing cells, with no differences between BD and HC. NKG2D expression on CD8+ T cells, serum IL-15 and soluble MICA were not significantly increased in BD. Our results do not suggest a T regulatory profile for GDCD8+ neither in HC, nor in BD. We cannot rule out other suppression mechanisms or some heterogeneity within this subset that could contribute to regulatory function. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20167234     DOI: 10.1016/j.imlet.2010.02.005

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  9 in total

1.  Interleukin-15 and its receptor (IL-15Rα) serve as new therapeutic implications for Behçet's disease.

Authors:  Yong He; Cheng Huang; Bao-Ming Wu; Jun Li
Journal:  Rheumatol Int       Date:  2013-09-18       Impact factor: 2.631

Review 2.  Quantitative peripheral blood perturbations of γδ T cells in human disease and their clinical implications.

Authors:  Ilan Bank; Victoria Marcu-Malina
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

3.  Effect of different cytokines in combination with IL-15 on the expression of activating receptors in NK cells of patients with Behçet's disease.

Authors:  Nilgun Sallakci; Ilhan Tahrali; Umut Can Kucuksezer; Esin Aktas Cetin; Ahmet Gul; Gunnur Deniz
Journal:  Immunol Res       Date:  2022-06-03       Impact factor: 4.505

Review 4.  Cancer Immunotherapy Using γδT Cells: Dealing with Diversity.

Authors:  Wouter Scheper; Zsolt Sebestyen; Jürgen Kuball
Journal:  Front Immunol       Date:  2014-11-20       Impact factor: 7.561

5.  Associations of MICA Polymorphisms with Inflammatory Rheumatic Diseases.

Authors:  Qingwen Wang; Xiaodong Zhou
Journal:  Open Rheumatol J       Date:  2015-11-24

Review 6.  Knitting the Threads of Silk through Time: Behçet's Disease-Past, Present, and Future.

Authors:  Fahd Adeeb; Austin G Stack; Alexander D Fraser
Journal:  Int J Rheumatol       Date:  2017-09-10

7.  Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease.

Authors:  Martina Bonacini; Alessandra Soriano; Alessandro Zerbini; Eleonora Calò; Luca Cimino; Francesco Muratore; Luigi Fontana; Luca Braglia; Maria Parmeggiani; Carlo Salvarani; Stefania Croci
Journal:  Front Immunol       Date:  2018-09-25       Impact factor: 7.561

8.  Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cells.

Authors:  Christian Peters; Hans-Heinrich Oberg; Dieter Kabelitz; Daniela Wesch
Journal:  Cell Mol Life Sci       Date:  2013-10-04       Impact factor: 9.261

Review 9.  Gamma Delta (γδ) T Cells and Their Involvement in Behçet's Disease.

Authors:  Md Samiul Hasan; Lesley Ann Bergmeier; Harry Petrushkin; Farida Fortune
Journal:  J Immunol Res       Date:  2015-10-11       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.